首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Neuro-oncology

缩写:NEURO-ONCOLOGY

ISSN:1522-8517

e-ISSN:1523-5866

IF/分区:13.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3796
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Xizi Wu,Daniel Ledbetter,Jen-Wei Tsai et al. Xizi Wu et al.
Background: Chordoma is a midline neoplasm accounting for approximately 20% of primary spinal tumors. Due to chordoma's locally aggressive nature, patients experience high rates of disease progression and have limited tre...
Zaira Seferbekova,Michael Ritter,Gleb Ruckhovich et al. Zaira Seferbekova et al.
Background: IDH-wildtype Glioblastoma (GB) is the most prevalent primary malignant CNS tumour in adults. The standard treatment regimen involves radiotherapy, which can cause radionecrotic (postactinic) changes as a late-...
Kristen L Drucker,Arijit Panda,Paul A Decker et al. Kristen L Drucker et al.
Background: Current literature suggests IDH-mutant astrocytoma contains several molecular subgroups. In this study we are interested in determining the connection between different molecular subgroups with grade and/or su...
Mohammad Asad,Julio Inocencio,Stefan Mitrasinovic et al. Mohammad Asad et al.
Background: Immunotherapy has yet to make significant gains in glioblastoma (GBM) treatment, due in part to GBM-mediated immune suppression. Increasing evidence points to critical roles for tumor-derived extracellular ves...
Maria Gómez-Mahiques,Carles Lopez-Mateu,F Javier Gil-Terrón et al. Maria Gómez-Mahiques et al.
Background: Precise delineation of non-contrast-enhancing tumor (nCET) in glioblastoma (GB) is critical for maximal safe resection, yet routine imaging cannot reliably separate infiltrative tumor from vasogenic edema. The...
Yangqing Li,Tao Kang,Zhen Jia et al. Yangqing Li et al.
Background: Glioblastoma (GBM) is a highly aggressive brain tumor, with glioblastoma stem cells (GSCs) occupying the pinnacle of a complex tumor microenvironment (TME), conferring therapeutic resistance. The TME plays a r...